Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
6.52M
-
Shares change
-
+276K
-
Total reported value, excl. options
-
$15.6M
-
Value change
-
+$1M
-
Number of buys
-
21
-
Number of sells
-
-20
-
Price
-
$2.39
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2017
51 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q2 2017.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.52M shares
of 29.5M outstanding shares and own 22.05% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (1.63M shares), VANGUARD GROUP INC (741K shares), InterWest Venture Management Co (580K shares), BlackRock Inc. (502K shares), Connor, Clark & Lunn Investment Management Ltd. (415K shares), FMR LLC (329K shares), WASATCH ADVISORS INC (254K shares), OxFORD Asset Management LLP (235K shares), Ancora Advisors, LLC (212K shares), and ClariVest Asset Management LLC (201K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.